The post-translational modification of proteins with polyubiquitin regulates virtually all aspects of cell biology. Eight distinct chain linkage types co-exist in polyubiquitin and are independently regulated in cells. This 'ubiquitin code' determines the fate of the modified protein 1 . Deubiquitinating enzymes of the ovarian tumour (OTU) family regulate cellular signalling by targeting distinct linkage types within polyubiquitin 2 , and understanding their mechanisms of linkage specificity gives fundamental insights into the ubiquitin system. Here we reveal how the deubiquitinase Cezanne (also known as OTUD7B) specifically targets Lys11-linked polyubiquitin. Crystal structures of Cezanne alone and in complex with monoubiquitin and Lys11-linked diubiquitin, in combination with hydrogen-deuterium exchange mass spectrometry, enable us to reconstruct the enzymatic cycle in great detail. An intricate mechanism of ubiquitin-assisted conformational changes activates the enzyme, and while all chain types interact with the enzymatic S1 site, only Lys11-linked chains can bind productively across the active site and stimulate catalytic turnover. Our work highlights the plasticity of deubiquitinases and indicates that new conformational states can occur when a true substrate, such as diubiquitin, is bound at the active site.
, but the physiological roles of most of these DUBs are unclear. By contrast, the A20-like OTU subfamily, identified by a larger catalytic domain (300-350 residues, Fig. 1a ), has been well studied. A20 is a tumour suppressor and negative feedback regulator of NF-κ B signalling 6, 7 ; TRABID (also known as ZRANB1) regulates transcription 8, 9 by targeting Lys29-and Lys33-linked chains 10 ; and VCPIP is associated with valosin-containing protein (VCP, also known as p97; ref. 11) and cleaves Lys48 and Lys11 linkages 2 . Cezanne regulates inflammation and NF-κ B signalling 12-14 , T-cell activation 15 , epidermal growth factor receptor (EGFR) trafficking 16 , and homeostasis of the transcription factors HIF-1α and HIF-2α 17, 18 . Cezanne and Cezanne2 (also known as OTUD7A; 61% identity with Cezanne) (Fig. 1a) are the only DUBs known to be specific for Lys11-linked polyubiquitin 2, 17, 19 . Lys11 specificity is encoded in the catalytic domain of Cezanne 2, 19 (Fig. 1b) , and extends to Lys11 linkages within Lys11/Lys63-and Lys11/Lys48-branched chains (Extended Data Fig. 1a) . A fluorescence resonance energy transfer (FRET)-based kinetic cleavage assay 20 showed that Cezanne has similar Michaelis constant (K M ) values for Lys11-, Lys63-and Lys48-linked diubiquitin, but a significantly higher catalytic turnover number (k cat ) for Lys11 diubiquitin ( Fig. 1c and Extended Data Fig. 1b, c) .
To understand the k cat -driven specificity of Cezanne, we determined crystal structures of Cezanne alone (Cez apo, 2.2 Å), in complex with monoubiquitin (Cez-Ub, 2.0 Å; two distinct complexes in the asymmetric unit), and bound to Lys11 diubiquitin (Cez-Lys11 diUb, 2.8 Å) ( Table 1 and Methods). Determination of the structure of Cez-Lys11 diUb used covalent diubiquitin activity-based probes (ABPs) 21 ( Fig. 1e, f) . In addition, an A20-Ub complex was determined at 2.85 Å (Fig. 1g , Extended Data Table 1 and Methods). The structures of Cezanne resemble those of A20 22, 23 and TRABID 10 with some topological differences (Extended Data Fig. 2 ).
Monoubiquitin-bound structures have not previously been available for the A20-like subfamily, and the Cez-Ub and A20-Ub complexes reveal a conserved S1 ubiquitin-binding site that is distinct from other OTU DUBs (Extended Data Fig. 3 ). The apo states of A20, Cezanne and TRABID feature an unobstructed S1 site, and A20-Ub is highly similar to unliganded A20 (r.m.s.d. 0.54 Å; Extended Data Fig. 3d ).
Monoubiquitin complexes depict product-bound rather than substrate-bound forms, and do not explain the specificity of DUBs. The Cez-Lys11 diUb complex represents a substrate-bound state that reveals a new S1′ site, and together the structures explain the specificity of Cezanne. Indeed, large-scale conformational changes between individual structures, in which the S1′ site is transiently formed and lost, delineate the catalytic cycle for Lys11 diubiquitin hydrolysis in Cezanne ( Cez apo is autoinhibited owing to the conformation of the Cys-loop 2 (residues 187-193) that precedes catalytic Cys194. Asn193 occupies the channel that binds the C-terminal tail of the distal ubiquitin, and the catalytic His358 is unable to deprotonate Cys194 ( Fig. 2b and Extended Data Fig. 4) . A key structural residue, His197, stabilizes the autoinhibited Cys-loop conformation (Fig. 2b) . Substantial conformational changes take place upon substrate binding (Fig. 2a) . The distal ubiquitin binds the accessible S1 site, while the proximal ubiquitin interacts with a new S1′ site formed by the α 3-α 4 linker (S1′ -loop hereafter) and by helices α 1 and α 2, which change in position and length ( Fig. 2a and Extended Data Fig. 4 ). These rearrangements enable hydrophobic residues (Leu155, Met203 and Phe206) to come together and bind the proximal ubiquitin (Extended Data  Fig. 4 ). His197 no longer coordinates the Cys-loop but now binds the S1′ -loop (Fig. 2c) . As a result, the Cys-loop moves, forming the oxyanion hole and enabling Cys194 to form the tetrahedral intermediate mimic with the diubiquitin ABP (Extended Data Fig. 2d) . Notably, the catalytic His358 does not coordinate Cys194 but remains in an inactive conformation, as the proximal ubiquitin pushes Thr188 of the Cysloop into the position of His358 in the catalytic centre ('His358-out' conformation; Fig. 2c ).
The next step in the cycle is illuminated by the two Cez-Ub complexes, which no longer feature an S1′ ubiquitin-binding site ( Fig. 2a and Extended Data Fig. 4) . Consistently, Cez-Ub shows no interaction with ubiquitin in NMR or fluorescence polarization measurements (Extended Data Fig. 5a, b) . Importantly, the two Cez-Ub complexes have different catalytic centres. Cez-Ub-A features the inactive 'His358-out' conformation ( Fig. 2d) , whereas Cez-Ub-B displays a catalytically competent state, in which Thr188 has moved out and His358 coordinates Cys194 (Fig. 2e and Extended Data Fig. 4) . His197 is again a key residue that now stabilizes the Cys-loop in the active state (Fig. 2e) , which hydrolyses the acyl intermediate to regenerate Cez apo (Fig. 2a) . The active state might also depict the initial Cys deprotonation stage before tetrahedral intermediate formation (within transition I, Fig. 2a) . Indeed, Cys194 and His358 are essential for hydrolysis of diubiquitin and a monoubiquitinated fluorescent Lys-Gly (KG) dipeptide (Ub-KG*
24
; Extended Data Fig. 5c, d ). Structure-based mutagenesis confirmed key mechanistic features of Cezanne. Mutation of Asn193 to Leu or Met stabilized autoinhibition of Cez apo by improving contacts in the ubiquitin-binding channel and abrogated DUB activity and ubiquitin binding (Fig. 3a, b and Extended Data Fig. 5e, f) . Mutation of His197 or its coordinating residue Asp210 to Ala reduced cleavage of diubiquitin and Ub-KG* (Extended Data  Fig. 5g, h ). Consistent with a key structural rather than catalytic role for His197, Cezanne H197A showed residual activity, and mutations maintaining its coordinating capabilities were only mildly impaired (Extended Data Fig. 5i-k) . Notably, mutation of the corresponding residue in A20, His106, also reduced A20 DUB activity (Extended Data Fig. 5l ).
Finally, hydrogen-deuterium exchange mass spectrometry (HDX-MS) confirmed the 'footprints' of bound ubiquitin moieties, and the conformational transitions observed crystallographically (Extended Data Figs 6, 7). The elongated α 2-helix that is disrupted in complex structures (Fig. 2a) displayed an uncharacteristically high hydrogendeuterium exchange for helices in Cez apo, suggesting that this helix may be dynamic in solution (Extended Data Fig. 6a, b) . Mutations that destabilize helix α 2 (I156G or L155G/I156G) impaired Cezanne activity (Fig. 3c, d and Extended Data Figs 5e, 6c), indicating that there is a required order-disorder transition in this region. Moreover, despite the lack of direct contacts, these mutants reduced ubiquitin binding to the S1 site (Extended Data Fig. 5f ). Ubiquitin binding substantially improved the thermal stability of Cezanne (Extended Data Fig. 8a) , and increased hydrogen-deuterium exchange was observed in multiple elements corresponding to the S1′ site upon ubiquitin release (Extended Data Fig. 7a, d ). This reveals that S1 site ubiquitin binding is coupled to S1′ site dynamics, and primes the enzyme for substrate discrimination and catalysis. Together, mutagenesis and HDX-MS confirm the observed conformational transitions in the catalytic cycle (Fig. 2) .
We next studied how these transitions impose linkage specificity. The small differences in K M among Lys11-, Lys63-and Lys48-linked diubiquitin (Fig. 1c) suggest that substrate engagement is primarily driven by the exposed S1 site, which involves the Cezanne α 5-α 6 helical arm and a hydrophobic loop (Fig. 3e) . These elements contact both Ile44 and Ile36 patches of ubiquitin as well as its C terminus. Mutations in the helical arm or in the channel for the ubiquitin C terminus abrogated hydrolysis of Lys11 diubiquitin and Ub-KG* (Fig. 3f and Extended Data Fig. 8b ) and reactivity towards the Lys11 diubiquitin ABP (Fig. 3g) . Monoubiquitin-binding assays indicated a strong interface (dissociation constant (K D ) 9.3 μ M for wild-type Cezanne, 0.43 μ M for Cezanne C194A; Extended Data Fig. 8c, d ). Moreover, monoubiquitin or differently linked diubiquitin bound Cezanne C194A similarly in pull-down assays, and this depended on a free ubiquitin C terminus; once the C terminus is removed, interactions are lost except for Lys11 diubiquitin, as this chain type can bind across the active site (Extended Data Fig. 8e ). Hence, the S1 site is responsible for substrate recruitment.
DUB linkage specificity relies on careful positioning of the proximal ubiquitin, which interacts with Cezanne via an unusual surface, involving Thr12, Glu16 and its α -helix (Asp32, Lys33, Glu34, Gly35; Fig. 3c and Extended Data Fig. 9a) . A similar interface is also used by UBE2S, the Lys11-specific E2 enzyme 25 . Proximal ubiquitin engagement transiently forms the S1′ site, enabling catalysis. However, consistent with the weak interface, mutations in hydrophobic S1′ site residues had little effect on DUB activity or probe reactivity (Extended Data Fig. 9b, c) .
Importantly, a direct interaction between Lys33 of the proximal ubiquitin and Glu157 of the catalytic centre ( Fig. 3c) affects Cezanne catalytic turnover. Cezanne hydrolysed Lys11 diubiquitin with proximal K33A or K33E mutations less efficiently than wild-type Lys11 diubiquitin (Extended Data Fig. 9d ). Cezanne E157K cleaved Ub-KG* ( Fig. 4a ) but showed severely impaired activity towards Lys11 diubiquitin substrates ( Fig. 4b and Extended Data Fig. 9e ). Kinetic analyses of this reaction reveal a drop in k cat for Lys11 diubiquitin hydrolysis by Cezanne E157K as compared to wild-type Cezanne, whereas Lys63 and Lys48 cleavage was almost unaffected ( Fig. 4c and Extended Data Fig. 1c, d ). Qualitative assays confirm that Cezanne E157K is less specific than wild-type Cezanne (Extended Data Fig. 9f, g ). Lys33 binding to Glu157 requires Cezanne to be in its inactive 'His358-out' conformation. Hence, Glu157 is important for substrate selection but not for catalysis, and while it can coordinate His358, its presence is not essential for the catalytic dyad of Cezanne.
Together, our findings illuminate a complete DUB catalytic cycle and reveal the molecular basis of Cezanne's Lys11 specificity (Fig. 4d) . The dynamic Cez apo state engages polyubiquitin at the S1 site, releasing Cys-loop-mediated autoinhibition. This primes the enzyme for substrate discrimination by S1′ site remodelling. Only Lys11-linked polyubiquitin forms favourable contacts with the S1′ site, which opens transiently to enable interactions between Lys33 and Glu157, and formation of this contact improves catalytic turnover. After isopeptide bond hydrolysis, conformational changes destroy the S1′ site and expel the proximal ubiquitin. The remaining product-bound monoubiquitin complex is resolved by further rearrangements that align the catalytic Fig. 6c ). e, The S1 site of Cezanne contacts the Ile44 patch (top left), the Ile36 patch (bottom left) and the C-terminal tail of the distal ubiquitin (bottom right). f, DUB assay of S1 site mutants. WT, wild-type. g, Lys11 diubiquitin ABP probe assay of S1 site mutants. All assays were performed at least twice with consistent results. For gel source images, see Supplementary Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. The apoenzyme is autoinhibited but dynamic, and recruits a substrate with its accessible S1 site. Only Lys11-linked diubiquitin can interact specifically with the formed S1′ site, involving an activating interaction between Cezanne and ubiquitin Lys33. After cleavage, the S1′ site is lost and the proximal moiety expelled. Subsequent hydrolysis and distal ubiquitin release recreates the Cezanne apo state.
Supplementary Information is available in the online version of the paper. 
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Cloning and site-directed mutagenesis. A codon-optimized human Cezanne gene (Otud7b) for bacterial expression was obtained from GeneArt Gene Synthesis (Invitrogen) and cloned into pOPIN vectors 26 using the In-Fusion HD Cloning Kit (Clontech) according to the manufacturer's instructions. Site-directed mutagenesis of Cezanne, A20 and ubiquitin (Ub) was performed using the QuikChange method. Protein expression and purification. Proteins were expressed in E. coli Rosetta2 (DE3) pLacI (Novagen) from the pOPIN-E (Cezanne) or pGEX6P1 (A20) vectors. The pOPIN-E vector introduces a C-terminal His6 tag and pGEX6P1 features a PreScission protease-cleavable N-terminal GST tag. Cells were grown at 37 °C to an optical density (OD) 600 of 0.8-1.0 and induced with 0.2-0.5 mM isopropyl β -d-1-thiogalactopyranoside (IPTG) for 18-20 h at 18 °C. Expression was performed in 2-4 L 2× TY medium supplemented with appropriate antibiotics.
All purification steps were performed at 4 °C. Bacterial cells were resuspended in 40-80 ml lysis buffer (25 mM Tris (pH 8.5), 200 mM NaCl, 5 mM DTT (A20) or 2 mM β -mercaptoethanol (Cezanne), 1 mg/ml lysozyme, 0.1 mg/ml DNaseI, one EDTA-free Complete Protease Inhibitor Cocktail tablet), sonicated and cleared by centrifugation at 20,000g for 35 min. His-tagged constructs were affinity purified with TALON Superflow resin (GE Healthcare). Resin (1-2 ml) was incubated with the cleared lysate for 5-10 min and washed with 1 l buffer A (25 mM Tris (pH 8.5), 200 mM NaCl, 2 mM β -mercaptoethanol). Protein was eluted with 5-10 ml buffer A supplemented with 250 mM imidazole and subsequently dialysed against buffer B (25 mM Tris (pH 8.5), 5 mM DTT) plus 50 mM NaCl before further purification (see below). Cleared lysates of GST fusion proteins were incubated with 2-4 ml glutathione sepharose 4B resin (GE Healthcare) for 1 h under constant agitation. The beads were washed with 2 l buffer B supplemented with 500 mM NaCl and 0.5 l buffer B plus 50 mM NaCl. GST tag cleavage was performed overnight with 50-100 μ g GST-tagged PreScission protease on the resin. Protein was eluted with buffer B plus 50 mM NaCl before further purification.
All proteins were subjected to anion-exchange chromatography (Resource Q, GE Healthcare) in buffer B with a salt gradient of 50-500 mM NaCl, and subsequent size-exclusion chromatography (HiLoad 16/60 Superdex 75, GE Healthcare) in buffer B supplemented with 200 mM NaCl. Peak fractions were pooled, concentrated to 2-25 mg/ml using Amicon 10 kDa MWCO Ultra Centrifugal Filters (Millipore), frozen in liquid nitrogen and stored at − 80 °C. Qualitative DUB assays. Qualitative in vitro deubiquitination assays were performed as described 27 . In short, DUBs were diluted in DUB dilution buffer (25 mM Tris (pH 7.5), 150 mM NaCl, 10 mM DTT) to 2× indicated concentrations and pre-incubated for 10 min at room temperature. 10 μ M stocks (2× final concentration) of differently linked diUb substrates were prepared in 2× DUB reaction buffer (100 mM Tris (pH 7.5), 100 mM NaCl, 10 mM DTT). To start the hydrolysis reaction, DUB and substrate solutions were mixed in a 1:1 ratio and incubated at 37 °C for the indicated times. Reactions were stopped by adding 4× LDS sample buffer (Invitrogen), resolved by SDS-PAGE on 4-12% gradient gels run in MES buffer (Invitrogen) and visualized by silver staining. Assembly of Ub chains for in vitro DUB assays and pull-down assays. Lys11-linked diUb variants were assembled using UBE2S 19 . To generate Ub moiety-specific mutations, such as Lys11 diUb with a proximal K33A or K33E mutation, chains were assembled using Ub (K11R, K63R) as the distal, and Ub (K63R, ∆ LRGG) variants as the proximal moiety. Lys11 diUb molecules carrying no further mutation are referred to as wild-type* (WT* ), and diUb substrates carrying additional proximal mutations are called 'K33A* ' and 'K33E* ' , respectively.
In order to generate specific branched triUb molecules containing a Lys11 linkage, the UBE2S assembly system was combined with UBE2N/UBE2V1 or UBE2R1 for Lys11/63 or Lys11/48 triUb, respectively 28 . Using Ub (∆ LRGG) with or without K63R mutation as the proximal Ub allowed the assembly of defined branches. Furthermore, distal Ub moieties contained mutations to prevent chain elongation, that is, Ub (K11R, K63R) and Ub (K11R, K48R, K63R) were used for Lys11/63 and Lys11/48-branched triUb, respectively. FRET-based DUB kinetics. Recently developed FRET-based diUb substrates were used to determine Michaelis-Menten kinetics for Cezanne variants 20 . Two Ub moieties linked via a native isopeptide linkage feature a donor (5-carboxyrhodamine110; Rho) or an acceptor (5-carboxytetramethylrhodamine; TAMRA) fluorophore, respectively. Lys11-and Lys48-linked diUb substrates of this type were used, while Lys63 FRET diUb was purchased from Boston Biochem (cat. no. UF-330). The change in fluorescence intensity (FI) of the donor fluorophore upon diUb hydrolysis was measured on a PheraStar plate reader (BMG Labtech), equipped with an FI optic module with λ ex = 485 nm and λ em = 520 nm (for Lys11 and Lys48 FRET diUb), or λ ex = 540 nm and λ em = 590 nm (for Lys63 FRET diUb). Reactions were performed in black, round-bottomed, non-binding 384-well plates (Corning) at 25 °C in a total volume of 15 μ l.
Non-fluorescent Lys11, Lys63 and Lys48 diUb molecules were serially diluted in FI buffer (20 mM Tris (pH 7.5), 100 mM NaCl, 2 mM DTT, 0.1 mg/ml BSA) and the respective FRET substrate was spiked in at a fixed concentration of 1 μ M (2× final concentration). In each well, 7.5 μ l substrate was mixed with 7.5 μ l enzyme at 2× indicated concentrations in FI buffer. All measurements for one experiment were performed in parallel in triplicate for each substrate concentration, and the change in FI was recorded over a period of 30-45 min at 15-s intervals. The maximal FI change was determined by using 25-50 nM Cez WT (Lys11 cleavage), 5 nM USP21 (Lys63 cleavage) or 0.5 μ M OTUB1 (Lys48 cleavage) as positive controls. The observed FI values were plotted against time, and initial velocities of diUb cleavage were calculated. These initial rates at a fixed Cezanne concentration were plotted against diUb substrate concentration, and Michaelis-Menten parameters were determined using Prism 6 (GraphPad Software, Inc.). In the case of Lys48 diUb cleavage by Cez E157K, where the determined K M value exceeded the highest tested diUb concentration, catalytic efficiencies were also calculated from a linear fit of the lower substrate concentration range (Extended Data Fig. 1d) . Modification of Cezanne with Ub-based suicide probes. Cezanne variants were diluted in DUB dilution buffer (25 mM Tris (pH 7.5), 150 mM NaCl, 10 mM DTT) to 11-μ M stocks, and mixed with 44 μ M diUb ABPs 21 in a 1:1 ratio. Reactions were incubated at 37 °C for 10-60 min, stopped with 4× LDS sample buffer (Invitrogen) and analysed on a Coomassie-stained SDS-PAGE gel.
Further Ub-based suicide probes used in this study include the Ub-haloalkyl probe Ub-C2Br 29 and Ub propargylamide (Ub-PA) 30 , which were used for the generation of Cez-Ub for crystallization (Ub-C2Br) as well as A20-Ub crystallization, fluorescence polarization-based Ub-binding assays, NMR and HDX-MS (Ub-PA), respectively. Crystallization. Crystallization screening was carried out in 96-well plates in a sitting-drop vapour diffusion setup using nano-litre robotics (typical drop size was 100+ 100 nl).
The first crystallized Cez apo construct (residues 88-438) contained an N-terminal flexible extension of 41 residues that was removed in subsequent crystallization attempts for Cez apo and complexes. Native (9.5 mg/ml) and selenomethionine (SeMet)-substituted (7.0 mg/ml) Cez apo (residues 88-438) crystals grew at 18 °C in 8% (w/v) PEG 8K, 0.1 M lithium chloride and 50 mM magnesium sulphate. Cez apo (residues 129-438, 8.0 mg/ml) crystallized in 0.1 M Bis-Tris pH 6.1 and 0.2 M magnesium formate at 18 °C.
Covalent complexes of Cezanne and A20 were generated with Ub-derived suicide probes (see above) and purified by anion-exchange chromatography and gel filtration. To obtain crystals of Cez-Ub, the long, unstructured V-loop (residues 267-291) was replaced by the corresponding sequence in TRABID (Gln-Pro-Gly; QPG). Cez (residues 129-438, QPG) was reacted with Ub-C2Br to form Cez-Ub, which was set up at a concentration of 21.7 mg/ml. Initial crystals grew from 0.1 M sodium acetate pH 4.6 and 8% (w/v) PEG 4K at 18 °C, and were used for streak seeding to obtain diffraction-quality crystals that grew from 0.1 M sodium acetate pH 4.8 and 6% (w/v) PEG 6K. For Cez-Lys11 diUb crystallization, Cez (residues 129-438) was reacted with Lys11-linked diUb ABP. The complex (6.7 mg/ml) crystallized at 18 °C in 0.1 M phosphate citrate pH 4.2, 20% (w/v) PEG 8K and 0.2 M sodium chloride. A20-Ub was generated from A20 (residues 1-366) and Ub-PA. Crystals were set up at a concentration of 8.0 mg/ml and grew from 0.1 M MES/ imidazole pH 6.5, 7% (w/v) PEG 8K and 20% ethylene glycol at 14 °C.
Prior to synchrotron data collection, crystals were vitrified in liquid nitrogen after brief soaking in mother liquor containing 27.5% glycerol (Cez apo, residues 88-438), 25% (v/v) PEG400 (Cez apo, residues 129-438), 30% (v/v) PEG400 (Cez-Ub), 28% glycerol (Cez-Lys11 diUb), or mother liquor alone (A20-Ub). Diffraction images were indexed and integrated using iMOSFLM 31 or XDS 32 , and scaled using SCALA 33 or its successor program AIMLESS 34 . The structure of Cez apo (residues 88-438) was solved by SAD phasing using diffraction data collected from a SeMet-substituted crystal. The automated structure solution pipeline SHARP and autoSHARP were used for SAD phasing 35, 36 , followed by iterative manual building using Coot 37 and refinement using PHENIX 38 . Electron density was not visible for the first 41 residues, which were removed from the construct for subsequent crystallization attempts.
Phases for subsequent Cez structures and for A20-Ub were obtained by molecular replacement in PHASER 39 , using Cez apo (88-438), Cez apo (129-438) or A20 apo (PDB 2VFJ 22 ), and Ub (PDB 1UBQ 40 ), as search models where appropriate. Models were built in Coot 37 and refined in PHENIX 38 in iterative rounds, using simulated annealing and TLS restraints where appropriate. Final Ramachandran statistics (favoured/allowed/outliers) were 98.5%/1.5%/0% (Cez apo), 99.1%/0.9%/0% (Cez-Ub), 98.6%/1.4%/0% (Cez-Lys11 diUb), and 97.1%/2.9%/0% (A20-Ub), respectively. Final data collection and refinement statistics are summarized in Extended Data Table 1 . Fluorescence polarization assays. Fluorescence polarization measurements were used to monitor the interaction between DUBs and FlAsH-tagged Ub, as well as the cleavage of a monoubiquitinated TAMRA-labelled Lys-Gly (KG) dipeptide (Ub-KG* ) 24 or Lys11-linked diUb-FlAsH. Measurements were performed using a PheraStar plate reader (BMG Labtech), equipped with an optic module for FlAsH (λ ex = 485 nm, λ em = 520 nm) or TAMRA (λ ex = 540 nm and λ em = 590 nm) detection. Fluorescence polarization values given in millipolarization (mP) were determined by taking the following polarization values into account: FlAsH-Ub (195 mP), TAMRA-KG (50 mP) and Lys11 diUb-FlAsH (315 mP). Assays were performed in triplicate in black, round bottom, non-binding surface 384-well plates (Corning) at 25 °C in 20 μ l.
For fluorescence polarization binding studies, FlAsH-Ub was diluted to 300 nM in fluorescence polarization buffer (20 mM Tris (pH 7.5), 100 mM NaCl, 2 mM β -mercaptoethanol, 0.1 mg/ml BSA). Serial dilutions in fluorescence polarization buffer were prepared of Cezanne variants, and 10 μ l of this was mixed with 10 μ l FlAsH-Ub in a 384-well plate. The plate was incubated in the dark for 10-15 min before the measurement. Fluorescence polarization values were fitted according to a 'one-site -total' binding model using Prism 6 (GraphPad Software, Inc.).
Fluorescence polarization cleavage assays were started by mixing 10 μ l per well enzyme at 2× indicated concentration in fluorescence polarization buffer to 10 μ l of predispensed fluorescence polarization substrate (Ub-KG* or Lys11-linked diUbFlAsH) at 300 nM. For the TAMRA-based substrate, TAMRA-KG was included as positive control. Hydrolysis reactions were followed for 1 h in 60-90 s intervals.
Fluorescence polarization values of TAMRA-measurements were fitted according to a 'one phase decay' model using Prism 6 (GraphPad Software, Inc.). NMR Ub-binding study with wild-type Cez apo and Cez-Ub. Cez WT (residues 129-438), a purified covalent Cez-Ub complex (assembled with Cez WT and Ub-PA), and 15 N-labelled Ub WT were dialysed against NMR buffer (18 mM Na 2 HPO 4 , 7 mM NaH 2 PO 4 xH 2 O, 150 mM NaCl, 5 mM DTT (pH 7.2)). Samples of 50 μ M 15 N-labelled Ub alone or in the presence of 130 μ M Cez WT or Cez-Ub were prepared in 350 μ l NMR buffer containing 20 μ l D 2 O, and were transferred into Shigemi NMR microtubes.
1 H-15 N BEST-TROSY (band-selective excitation short-transient transverse relaxation-optimized spectroscopy) spectra were recorded at 298 K on a Bruker AvanceII+ 700 MHz spectrometer with a TCI triple resonance probe. Data were processed in TopSpin 3.0 (Bruker Inc.) and analysed in Sparky (UCSF). Thermal shift assay. Protein melting curves were recorded on a Corbett RG-6000 real-time PCR cycler. Samples contained 3 μ M Cez (residues 129-438) WT or C194A, 3× SYPRO Orange, and 0-400 μ M Ub. Data were recorded in triplicate and in two independent experiments. Melting temperatures (T m ) in the presence of Ub were referenced to 45.9 ± 0.2 °C (WT) and 45.0 ± 0.2 °C (C194A). Pull-down assay. His-tagged Cezanne constructs were used for in vitro pull-downs of purified Ub and diUb variants. For each reaction, 5 μ l TALON Superflow resin (GE Healthcare) was equilibrated with PD buffer (20 mM Tris (pH 7.5), 100 mM NaCl, 2 mM β -mercaptoethanol), mixed with 20 μ g His-tagged bait in 400 μ l PD buffer plus 0.1 mg/ml BSA, incubated for 20 min at 4 °C under constant agitation, and subsequently washed three times. Ub and diUb prey proteins were diluted in PD buffer plus BSA to 1.2 μ g/ml and 2.4 μ g/ml, respectively, and 400 μ l was added to the immobilized bait. After incubation for 1 h at 4 °C, the resin was washed three times with PD buffer before the addition of 50 μ l of 4× LDS sample buffer (Invitrogen). Samples were boiled for 1 min, and 20 μ l per sample was analysed by SDS-PAGE and silver staining. Hydrogen-deuterium exchange mass spectrometry (HDX-MS). Deuterium exchange reactions of Cezanne were initiated by diluting the protein in D 2 O (99.8% D 2 O ACROS, Sigma) in 10 mM Tris pH 7.5 buffer to give a final D 2 O percentage of 95.3%. For all experiments, deuterium labelling was carried out at 23 °C (unless otherwise stated) at four time points (3 s on ice (0.3 s), 3 s, 30 s and 300 s). The labelling reaction was quenched by the addition of chilled 2.4% (v/v) formic acid in 2 M guanidinium hydrochloride, and immediately frozen in liquid nitrogen. Samples were stored at − 80 °C before analysis.
The quenched protein samples were rapidly thawed and subjected to proteolytic cleavage by pepsin followed by reversed phase HPLC separation. Briefly, the protein was passed through an Enzymate BEH immobilized pepsin column, 2.1 × 30 mm, 5 μ m (Waters, UK) at 200 μ l/min for 2 min and the peptic peptides trapped and desalted on a 2.1 × 5 mm C18 trap column (Acquity BEH C18 Vanguard pre-column, 1.7 μ m, Waters). Trapped peptides were subsequently eluted over 12 min using a 5-36% gradient of acetonitrile in 0.1% (v/v) formic acid at 40 μ l/min. Peptides were separated on a reverse phase column (Acquity UPLC BEH C18 column 1.7 μ m, 100 mm × 1 mm (Waters). Peptides were detected on a SYNAPT G2-Si HDMS mass spectrometer (Waters) acquiring over an m/z of 300-2,000, with the standard electrospray ionization (ESI) source and lock mass calibration using [Glu1]-fibrino peptide B (50 fmol/μ l). The mass spectrometer was operated at a source temperature of 80 °C and a spray voltage of 2.6 kV. Spectra were collected in positive ion mode.
Peptide identification was performed by MS e using an identical gradient of increasing acetonitrile in 0.1% (v/v) formic acid over 12 min. The resulting MS e data were analysed using Protein Lynx Global Server software (Waters) with an MS tolerance of 5 ppm.
Mass analysis of the peptide centroids was performed using DynamX software (Waters). Only peptides with a score > 6.4 were considered. The first round of analysis and identification were performed automatically by the DynamX software, however, all peptides (deuterated and non-deuterated) were manually verified at every time point for the correct charge state, presence of overlapping peptides, and correct retention time. Deuterium incorporation was not corrected for backexchange and represents relative, rather than absolute changes in deuterium levels. Changes in H-D amide exchange in any peptide may be due to a single amide or a number of amides within that peptide. All time points of a data set (that is, data of related constructs) were prepared simultaneously and were acquired on the mass spectrometer on the same day.
